OrbitonOpen research workspace →

Apotex Health Corp.

TSX:APTXLive AI agent

Apotex is a Canadian-based global health company dedicated to delivering accessible, innovative medicines and health products to people worldwide.

Investor website: https://apotex.com/

About

Apotex is a Canadian-based global health company dedicated to delivering accessible, innovative medicines and health products to people worldwide. With over 6,000 team members, the company operates in approximately 141 countries and has a manufacturing capacity of 63 billion doses, offering a diverse portfolio of 2,443 pharmaceutical and consumer health products.

Verified company data

Shares outstanding
228,499,020
Fully diluted shares
247662946
Projects
["Biosimilars: Creating pathways to biosimilars. As a pioneer in oncology biosimilars, we’re transforming access to affordable therapies through innovation, development, and partnerships. With continued investment and an expanding portfolio in new therapeutic areas, we’re breaking barriers to care—delivering high-quality, effective treatments without compromise. - 1&2 top selling biosimilars in Canada - #1 oncology patient support program. [Learn more about our portfolio of biosimilars](https://www.apobiologix.com/en/our_portfolio.asp)","Generics: A force for accessible medicine. As the leader in Canadian generics pharmaceuticals and top 5 in the United States, we bring our experience and track record of making generics affordable and accessible worldwide. Apotex is committed to delivering access with uncompromising quality. With an extensive portfolio of high-quality generic medicines and a robust R&D pipeline, we’re offering accessible treatment worldwide, meeting patients’ needs throughout their lives. Our generic medicines are available in various dosage forms, including oral solid doses and suspensions, capsules, injectables, sprays, powders, inhalers, and drops. - ~460 generic products - ~70 countries where generics are distributed - #1 in prescription volume in Canada - Top ten in the United States - #4 in Mexico's private generics market. Generics play a vital role in empowering patients to achieve better health. They are safe, effective, affordable, and trusted by billions around the world.","Consumer health: Empowering consumers to take charge of their health. Supporting people along their health journeys, our vitamins, supplements and other high-quality natural health products are designed by licensed health practitioners to support optimal health and well-being and delivered to consumers through well-established brands and distribution channels. Learn more about our natural health product brands: - [CanPrev](https://canprev.ca/) - [Orange Naturals](https://orangenaturals.com/) - [CytoMatrix](https://cytomatrix.ca/)"]
Leadership
Jeff Watson (President & CEO, Jeff Watson is the President & Chief Executive Officer (CEO) of Apotex.), Ariel Alon (Chief Operations Officer, Ariel Alon is Apotex’s Chief Operations Officer.), Barry Fishman (Chief Corporate Development Officer, Barry Fishman is the Chief Corporate Development Officer at Apotex.), Brian McClelland (Chief Financial Officer, As Chief Financial Officer, Brian McClelland oversees Apotex's Global Finance and Global Information Services functions.), Carina Vassilieva (Chief Human Resources Officer, Carina Vassilieva is the Chief Human Resources Officer at Apotex.), Christine Baeder (President, Apotex USA and LATAM, Christine Baeder is the President of Apotex USA and LATAM), Francesco Tallarico (Chief Legal Officer and Global Head of Government Relations, Francesco Tallarico serves as the Chief Legal Officer at Apotex, leading the Global Legal, Compliance, Government Relations, and Communications functions.), Kiran Krishnan (Senior Vice President, Global Regulatory Affairs, Kiran Krishnan, PhD is the Senior Vice President of Global Regulatory and Medical Affairs at Apotex.), Martin Arès (President, Apotex Canada and Rest of World (ROW), Martin Arès is the President of Apotex Canada and Rest of World (ROW)), Pradeep Sanghvi (Executive Vice President, Global Research and Development, Pradeep Sanghvi is Executive Vice President, Global Research and Development at Apotex.)

Verified data last updated:

Recent filings